Health ❯ Healthcare ❯ Clinical Guidelines

Treatment Protocols

Combination Therapy Diabetes Management Radiotherapy Empiric Therapy Standard of Care Medications Lifestyle Interventions High BMI Patients Alzheimer's Disease Management Hospitalization Criteria REBOOT Trial Medication Use Sex-Specific Treatment Advanced Skin Cancer Medication Management Hormone Receptor Status Medication Recommendations Antiplatelet Therapy Guidelines Patient Eligibility Intoxication Management Antibody Treatments for RSV Pediatric Treatment DAPT Recommendations Long-term Management Chemotherapy Infection Management Neonatal Treatment Weight Management EGFR-Mutant Lung Cancer Oncology Treatments IBS Management Drug Administration BTK Inhibitors Treatment-Naive Patients STI Management Multidisciplinary Approaches Drug Development Beta-Blocker Use Thrombolysis Antenatal Treatments Simplified Regimens Citisine Administration Glycemic Control Antibiotic Use in Children Nasal Congestion Management Heart Failure Management Type 2 Diabetes Adjuvant Therapy American Heart Association Guidelines Androgen Deprivation Therapy Combination Therapies Second-Line Therapy Vision Improvement

Kodiak Drugs Clear Phase 3 for Wet AMD and Shares Soar

The company said it will seek U.S. approval by filing a Biologics License Application for Zenkuda in Q4 to pursue its first commercial product.

B7‑H3 Antibody‑Drug Conjugates Cut Death Risk by Half in Relapsed Small‑Cell Lung Cancer

Eplontersen Fails to Cut Cardiovascular Deaths or Recurrent Events in Large ATTR-CM Trial

Study Finds 22.8 Million More Americans Eligible for Blood Pressure Drugs

Meta-Analysis Backs Low-Dose Digitalis for Heart Failure With Fewer Worsening Events

Novo Nordisk’s Oral Semaglutide Lowers HbA1c in Teens in Pivotal Trial

Trial Finds Stopping Beta-Blockers After Heart Attack Safe for Selected Low-Risk Patients

HI-PEITHO Finds Catheter Ultrasound Thrombolysis Halves 30-Day Events in Intermediate-Risk PE

Single Daily Bictegravir–Lenacapavir Pill Matches Complex HIV Regimens in Phase III

Global Study Finds Wide Gaps in Use of Antenatal Magnesium Sulfate, With Steroids Applied More Consistently

CagriSema Beats Semaglutide on HbA1c and Weight at 68 Weeks in Type 2 Diabetes Trial

Ianalumab Plus Eltrombopag Extends Disease Control in Phase 3 ITP Study Published in NEJM

Pirtobrutinib Extends First-Line PFS vs BR and Shows Higher Response Rates Than Ibrutinib in CLL/SLL

FDA Approves Epkinly Monotherapy and Triplet Regimen for Relapsed Follicular Lymphoma

Southeast Asia Study Finds First-Line Neonatal Sepsis Treatments Often Ineffective

Baxdrostat Lowers Blood Pressure in Hard-to-Treat Patients in Phase III Trial

TACSI Trial Finds No Benefit of Dual Antiplatelet Therapy After CABG, Higher Bleeding Risk

ESC Trials Back Shorter Antiplatelet Therapy for Selected MI Patients

Trials Recast Post–Heart Attack Beta-Blocker Use, With Signal of Harm in Women

GLP-1 Agonists Cut Dementia and Mortality Risk Versus Metformin in Type 2 Diabetes